Evaluating ground glass opacities (GGO) in the COVID-19 era. Do autoantibodies help?
Чланак у часопису (Објављена верзија)
Метаподаци
Приказ свих података о документуАпстракт
Introduction: COVID-19 is an infectious disease, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and there have been outbreaks worldwide. The presentation may include unspecific and mild symptoms, myalgia, headaches, high fever, dry cough, severe dyspnea and acute respiratory distress syndrome (ARDS). Case study: We present a rare case of microscopic polyangiitis (MPA) with interstitial lung disease and without renal involvement misdiagnosed as COVID-19. Conclusions: Differential diagnosis of COVID-19 is extremely important, and must be correctly identified in order to proceed with correct treatment.
Кључне речи:
COVID-19 / interstitial lung disease / microscopic polyangiitisИзвор:
Journal of Infection in Developing Countries, 2022, 16, 9, 1530-1532Издавач:
- Journal of Infection in Developing Countries
DOI: 10.3855/jidc.16401
ISSN: 2036-6590
WoS: 000870826600023
Scopus: 2-s2.0-85139798074
Институција/група
PharmacyTY - JOUR AU - Pejić, Nina AU - Stojković Lalošević, Milica AU - Štulić, Miloš AU - Ćulafić, Milica AU - Ćulafić, Đorđe PY - 2022 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4343 AB - Introduction: COVID-19 is an infectious disease, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and there have been outbreaks worldwide. The presentation may include unspecific and mild symptoms, myalgia, headaches, high fever, dry cough, severe dyspnea and acute respiratory distress syndrome (ARDS). Case study: We present a rare case of microscopic polyangiitis (MPA) with interstitial lung disease and without renal involvement misdiagnosed as COVID-19. Conclusions: Differential diagnosis of COVID-19 is extremely important, and must be correctly identified in order to proceed with correct treatment. PB - Journal of Infection in Developing Countries T2 - Journal of Infection in Developing Countries T1 - Evaluating ground glass opacities (GGO) in the COVID-19 era. Do autoantibodies help? VL - 16 IS - 9 SP - 1530 EP - 1532 DO - 10.3855/jidc.16401 ER -
@article{ author = "Pejić, Nina and Stojković Lalošević, Milica and Štulić, Miloš and Ćulafić, Milica and Ćulafić, Đorđe", year = "2022", abstract = "Introduction: COVID-19 is an infectious disease, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and there have been outbreaks worldwide. The presentation may include unspecific and mild symptoms, myalgia, headaches, high fever, dry cough, severe dyspnea and acute respiratory distress syndrome (ARDS). Case study: We present a rare case of microscopic polyangiitis (MPA) with interstitial lung disease and without renal involvement misdiagnosed as COVID-19. Conclusions: Differential diagnosis of COVID-19 is extremely important, and must be correctly identified in order to proceed with correct treatment.", publisher = "Journal of Infection in Developing Countries", journal = "Journal of Infection in Developing Countries", title = "Evaluating ground glass opacities (GGO) in the COVID-19 era. Do autoantibodies help?", volume = "16", number = "9", pages = "1530-1532", doi = "10.3855/jidc.16401" }
Pejić, N., Stojković Lalošević, M., Štulić, M., Ćulafić, M.,& Ćulafić, Đ.. (2022). Evaluating ground glass opacities (GGO) in the COVID-19 era. Do autoantibodies help?. in Journal of Infection in Developing Countries Journal of Infection in Developing Countries., 16(9), 1530-1532. https://doi.org/10.3855/jidc.16401
Pejić N, Stojković Lalošević M, Štulić M, Ćulafić M, Ćulafić Đ. Evaluating ground glass opacities (GGO) in the COVID-19 era. Do autoantibodies help?. in Journal of Infection in Developing Countries. 2022;16(9):1530-1532. doi:10.3855/jidc.16401 .
Pejić, Nina, Stojković Lalošević, Milica, Štulić, Miloš, Ćulafić, Milica, Ćulafić, Đorđe, "Evaluating ground glass opacities (GGO) in the COVID-19 era. Do autoantibodies help?" in Journal of Infection in Developing Countries, 16, no. 9 (2022):1530-1532, https://doi.org/10.3855/jidc.16401 . .